Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02711345
Title A Phase I Clinical Study With Investigational Compound LTT462 in Adult Patients With Specific Advanced Cancers
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

melanoma

Therapies

LTT462

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.